And

are now a part of the new and improved

search Created with Sketch.
search Created with Sketch.

Advertisement

Dermwire News

News | July 14, 2020

High Kissability Marks for Restylane Kysse in New Phase 4 Study

In a recent first-of-its-kind phase IV, Kissability study for an injectable hyaluronic acid (HA) lip filler, subject satisfaction as well as partner satisfaction were evaluated following treatment with Restylane Kysse. Many consumers...

Read More

News | July 13, 2020

Cutera Launches Fraxis PRO

Cutera, Inc. is launching Fraxis PRO progressive dermal remodeling technology. Fraxis PRO combines fractional CO2 for skin resurfacing and radiofrequency microneedling for dermal remodeling in a single device. Fraxis PRO...

Read More

News | July 10, 2020

Azitra Awarded Patent for Engineered Bacterial Strain Discovery Platform

Azitra, Inc. has been issued a patent for the company’s engineered bacterial strain discovery platform. The United States Patent and Trademark Office (USPTO) has issued US Patent No. 10,702,558, which includes broad composition of...

Read More

News | July 9, 2020

Leo Pharma: FDA Accepts BLA for Tralokinumab for AD

The FDA has accepted the Biologics License Application (BLA) for Leo Pharma’s tralokinumab for the treatment of adults with moderate-to-severe atopic dermatitis (AD), the company says. A taget action date has been set in the second...

Read More

News | July 9, 2020

New Infographic Compare Rashes to COVID Toes

A new infographic from First Derm compares and contrasts rashes associated with COVID-19.

Read More

Advertisement

The Latest News

Advertisement

View more